Migraine usually results in functional impairment during attacks [1, 2] ; the condition is therefore a cause of disability. The WHO definition of disability [3] is any restriction or lack of ability to perform an activity in the manner or within the range considered normal for a human being. The migraine disability assessment (MIDAS) questionnaire has been developed to assess headache-related disability, and has been shown to be a valid instrument for this purpose in English-speaking migraine patients [4, 5] .
Abstract Migraine is associated with functional impairment. The migraine disability assessment (MIDAS) scale is a scientific instrument which captures headache-related disability. The Italian version of MIDAS was developed through a multi-step standardized methodology. Studies on Italian clinical samples showed that migraine patients were disabled in all activity domains. Non-work activities were more affected than work activities. Among patients in paid work, most continued working with a headache attack, although productivity was significantly reduced. The Italian MIDAS was used also in patients with transformed migraine and drug overuse. These patients were markedly disabled. MIDAS scores were higher than those found in migraine patients. When disability was assessed after 6 months from withdrawal therapy, MIDAS scores were significantly lower than at baseline. Our results confirmed the negative impact of the lives of headache patients, and suggest the use of MIDAS as a sensitive outcome measure for monitoring patients' progress. The study also indicated that patients attending a Headache Centre are on average more impaired than migraineurs in the general population. Among the studied patients, 35% had MIDAS grades I-II, and 65% had grades III-IV, while population-based studies report that around 43% of subjects have grades I-II disability, and 57% have grades III-IV [4, 5] .
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Following validation, we used the Italian MIDAS in clinical studies. We assessed disability in 225 consecutive migraine patients [8] . Most reported severe disability (mean MIDAS score 20). Analysis by activity domains showed that non-work activities were more affected than work activities, in terms of missed days (missed days in household, 4.6+missed days in family-social-leisure activities, 4.6=total 9.2; missed days of paid work=2) (Fig. 1) . Among patients in paid work, most continued working with a headache attack, although their productivity was significantly impaired. Patients had more days in which productivity was reduced by more than 50% than days lost due to headache (6.6 vs. 2.1).
MIDAS in transformed migraine
We also used MIDAS to assess patients with transformed migraine (TM) [9] , the form characterised by daily or neardaily headaches that had once been migraine. Sixty-two patients with TM and drug overuse (diagnosed according to the criteria proposed by Silberstein et al. [10] ) completed the MIDAS questionnaire before they underwent in-patient treatment consisting of abrupt withdrawal of the overused drug, detoxification, and prophylaxis with antimigraine drugs or antidepressants. After discharge, these patients were given a diary card to record headache frequency and drug consumption, and were asked to come back after three and six months. Mean baseline MIDAS score (all patients) was high (64.8), and all activity domains were compromised. Forty-nine patients completed the study. At the six-month assessment both frequency and analgesic consumption were markedly reduced in those who completed the study (mean days with headache per month, from 30 to 8.3; mean drugs per month, from 44.4 to 12.6). Mean MIDAS score was 60.2 in these patients at first compilation and 24.8 six months from withdrawal (p<0.0001, Student's t test) (Fig. 2) . These findings show that most TM patients with drug overuse are highly disabled and that appropriate management can improve their ability to function, as shown by the change in MIDAS score.
Migraine without aura 
Conclusions
Migraine has a negative impact on the lives on those who suffer from it. The MIDAS questionnaire is a simple instrument for evaluating disability in all activity domains. Studies conducted at our centre on Italian migraine patients show that the Italian MIDAS retains the simplicity and reliability of the original questionnaire. Our subsequent studies showed that MIDAS is a useful tool for follow-up and for outcome assess- 
